23andMe offers at-home test for breast cancer gene mutations

The DNA testing company 23andMe has gotten FDA approval to screen for 3 BRCA gene mutations linked to a higher risk of breast cancer. But the test raises some concerns. Katie Nielsen of CBS San Francisco station KPIX reports.
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news